0001209191-15-032284.txt : 20150403 0001209191-15-032284.hdr.sgml : 20150403 20150403162248 ACCESSION NUMBER: 0001209191-15-032284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150401 FILED AS OF DATE: 20150403 DATE AS OF CHANGE: 20150403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 201 REDWOOD SHORES PARKWAY, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 201 REDWOOD SHORES PARKWAY, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wahlstrom Mats CENTRAL INDEX KEY: 0001459154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 15751508 MAIL ADDRESS: STREET 1: 500 GOLDEN RIDGE ROAD, SUITE 100 CITY: GOLDEN STATE: CO ZIP: 80401 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-01 0 0001512762 Coherus BioSciences, Inc. CHRS 0001459154 Wahlstrom Mats C/O COHERUS BIOSCIENCES, INC. 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY CA 94065 1 0 0 0 Common Stock, $0.0001 par value 709482 I See Footnote Common Stock, $0.0001 par value 53583 I See Footnote Stock Option (Right to Buy) 29.00 2015-04-01 4 A 0 20000 0.00 A 2025-03-31 Common Stock 20000 20000 D Stock Option (Right to Buy) 29.00 2015-04-01 4 A 0 75000 0.00 A 2025-03-31 Common Stock 75000 75000 D The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein. The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein. The underlying shares subject to the option vest and become exercisable in full on the earlier of (i) one year from the 2015 Annual Meeting scheduled for May 21, 2015, or (ii) the date of the 2016 Annual Meeting, subject to Reporting Person's continued service relationship with the Issuer on such vesting date. Option granted to Reporting Person pursuant to his position as Chairman of the Audit Committee and Lead Independent Director. The underlying shares subject to the option vest and become exercisable in full on the earlier to occur of (i) one year from the 2015 Annual Meeting to be held on May 21, 2015, or (ii) the date of the 2016 Annual Meeting, subject to Reporting Person's continued service relationship with the Issuer on such vesting date. /s/ Matthew R. Hooper, as Attorney-in-Fact for Mats Wahlstrom 2015-04-03